BURLINGTON, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to ...
BURLINGTON, Mass. - scPharmaceuticals Inc. (NASDAQ:SCPH), a cardiorenal healthcare company with a market capitalization of $255 million and currently trading at $4.78, announced Thursday it has ...
FDA approves FUROSCIX® for use in pediatric patients weighing 43kg or aboveUSPTO issues five patents for FUROSCIX ReadyFlow™ AutoinjectorWESTLAKE ...
SAN DIEGO and ZUG, Switzerland, July 8, 2019 /PRNewswire/ -- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and SQ Innovation AG today announced that the two companies have entered into long-term, ...
Furosemide Lasix is a written diuretic water pill that is ineffective to eliminate generic drugs furosemide and disrupt from the body. In the lungs, salt composed of sodium and clinical, water, and ...
Stocktwits on MSN
MannKind stock slips despite FDA clearing pediatric use of heart failure drug — what’s spooking investors?
The FDA expanded Furoscix use to certain pediatric patients. ・MannKind received five new U.S. patents supporting its ...
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Furosemide for Injection in the ...
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, is introducing Furosemide for Injection, which is the generic of Lasix. Furosemide is indicated in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback